A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) C07K 16/28 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2266315
The invention provides methods of preventing acute rejection following renal or other solid organ transplantation. The methods entail administering, e.g., intravenously, to a transplant patient a monoclonal antibody which binds to the p55 subunit of the human interleukin-2 (IL-2) receptor of human T lymphocytes. The monoclonal antibody is preferably a chimeric or humanized antibody that blocks binding of IL-2 to the IL-2 receptor. In some methods, a single dose of about 1 mg/kg of antibody is administered about every other week, commencing immediately prior to transplantation and continuing until 8 weeks after transplantation.
Méthodes pour prévenir une crise de rejet suivant la transplantation d'un rein ou d'un autre organe solide. Cette méthode consiste à administrer au patient transplanté, p.ex. par voie intraveineuse, un anticorps monoclonal qui se lie à la sous-unité p55 du récepteur d'interleukine-2 humaine (IL 2) des lymphocytes T humains. L'anticorps monoclonal est de préférence un anticorps chimère ou humanisé qui bloque la liaison de l'IL-2 au récepteur d'IL-2. Dans certaines méthodes, une dose unique d'environ 1 mg/kg d'anticorps est administrée environ une semaine sur deux, en commençant immédiatement avant la transplantation et en continuant environ 8 semaines après la transplantation.
Light Susan
Queen Cary
Fetherstonhaugh & Co.
Hoffmann La Roche Inc.
Protein Design Labs Inc.
LandOfFree
Method of preventing acute rejection following solid organ... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of preventing acute rejection following solid organ..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of preventing acute rejection following solid organ... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1846942